Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence.

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• Hepatitis C virus (HCV) genotype is critical for treatment decisions and research.
• Limited availability of reliable HCV genotyping assays hinders clinical practice and studies.
• Accurate subtype identification is essential for emerging anti-HCV therapies.

Purpose of the Study:

• To develop and evaluate a novel microarray-based molecular technique for comprehensive HCV genotyping.
• To assess the accuracy and reliability of this assay for identifying HCV genotypes and subtypes.

Main Methods:

• Utilized low-density hydrogel biochips with genotype- and subtype-specific oligonucleotides targeting the NS5B region of the HCV genome.
• Involved amplification of a 380-nucleotide fragment of NS5B and subsequent hybridization on the biochip.
• Tested the assay on 345 HCV-positive samples.

Main Results:

• The microarray assay demonstrated 100% agreement with NS5B sequencing for genotype identification.
• Subtype identification showed 99.7% concordance with NS5B sequencing.
• Perfect agreement was observed for common subtypes including 1a, 1b, 4a, 4d, and 3a.

Conclusions:

• The developed microarray technique offers a highly accurate and promising tool for HCV genotyping.
• This assay facilitates precise identification of clinically relevant HCV subtypes, supporting new anti-HCV drug implementation.
• The method enhances capabilities for HCV epidemiological and clinical research.